News

Podcast

EyePod: Modifier Gene Therapy: What is it?

In this episode of EyePod, David Hutton sits down with Neena Haider, PhD, and Arun Upadhyay, PhD, to talk about modifier gene therapy.

In this episode of EyePod, David Hutton sits down with Neena Haider, PhD, and Arun Upadhyay, PhD, to talk about modifier gene therapy.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
Arjan Hura, MD, highlights the clinical and surgical updates at CIME 2024
Jay Barth, MD
Moving beyond the drop: CEO provides updates on Oyster Point's pipeline
Related Content
FDA grants RMAT designation to Atsena Therapeutics' gene therapy for XLRS
April 16th 2025

FDA grants RMAT designation to Atsena Therapeutics' gene therapy for XLRS

Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics
August 30th 2024

Latest advances in X-linked retinitis pigmentosa: Optimizing diagnosis and developments in gene therapy

Ocular clues aid in identifying neuromyelitis optica spectrum disorder
March 7th 2025

Ocular clues aid in identifying neuromyelitis optica spectrum disorder

Eyepod: Ocugen CEO gives update on OCU400
October 2nd 2023

Eyepod: Ocugen CEO gives update on OCU400

Study demonstrates visual acuity improvements following gene therapy for AIPL1-associated inherited retinal dystrophies
February 28th 2025

Study demonstrates visual acuity improvements following gene therapy for AIPL1-associated inherited retinal dystrophies

An illustration of an eye with a DNA helix in the pupil. Image credit: ©artacet – stock.adobe.com
February 20th 2025

Efficacy and safety findings for lenadogene nolparvovec (Lumevoq) from REFLECT Phase III trial

© 2025 MJH Life Sciences

All rights reserved.